Publications:

SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia-free survival.

Blood Advances

Wudhikarn, Kitsada K; Loghavi, Sanam S; Mangaonkar, Abhishek A AA; Al-Kali, Aref A; Binder, Moritz M; Carr, Ryan R; Reichard, Kaaren K; Finke, Christy C; Howard, Matthew M; Gangat, Naseema N; Tefferi, Ayalew A; Komrokji, Rami R; Ali, Najla N; Lasho, Terra T; Ketterling, Rhett R; Padron, Eric E; Patnaik, Mrinal M MM

Publication Date: 2020-11-24

Variant appearance in text: JAK2: E283K

PubMed Link: 33216886

Variant Present in the following documents:

• Main text

View BVdb publication page